tiprankstipranks
Renalytix AI Plc (GB:RENX)
LSE:RENX

Renalytix AI (RENX) Share Price & Analysis

5 Followers

RENX Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range10.00p - 150.00p
Previous Close11p
Volume124.08K
Average Volume (3M)335.86K
Market Cap
£16.98M
Enterprise Value20.71M
Total Cash (Recent Filing)$4.70M
Total Debt (Recent Filing)$9.42M
Price to Earnings (P/E)
Beta2.33
Oct 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding154,368,191
10 Day Avg. Volume223,941
30 Day Avg. Volume335,855
Standard Deviation0.27
R-Squared0.07
Alpha0.11
Financial Highlights & Ratios
Price to Book (P/B)-3.14
Price to Sales (P/S)41506.58
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.08
Enterprise Value/Gross Profit28.76
Enterprise Value/Ebitda-0.57
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

35.21%0.00%0.10%64.69%
35.21% Insiders
0.10% Other Institutional Investors
64.69% Public Companies and
Individual Investors

RENX FAQ

What was Renalytix AI Plc’s price range in the past 12 months?
Renalytix AI Plc lowest share price was 10.00p and its highest was 150.00p in the past 12 months.
    What is Renalytix AI Plc’s market cap?
    Currently, no data Available
    When is Renalytix AI Plc’s upcoming earnings report date?
    Renalytix AI Plc’s upcoming earnings report date is Oct 29, 2024 which is in 115 days.
      How were Renalytix AI Plc’s earnings last quarter?
      Renalytix AI Plc released its earnings results on May 15, 2024. The company reported -0.063p earnings per share for the quarter, missing the consensus estimate of -0.036p by -0.028p.
        Is Renalytix AI Plc overvalued?
        According to Wall Street analysts Renalytix AI Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Renalytix AI Plc pay dividends?
          Renalytix AI Plc does not currently pay dividends.
          What is Renalytix AI Plc’s EPS estimate?
          Renalytix AI Plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Renalytix AI Plc have?
          Renalytix AI Plc has 154,368,200 shares outstanding.
            What happened to Renalytix AI Plc’s price movement after its last earnings report?
            Renalytix AI Plc reported an EPS of -0.063p in its last earnings report, missing expectations of -0.036p. Following the earnings report the stock price went down -4.082%.
              Which hedge fund is a major shareholder of Renalytix AI Plc?
              Currently, no hedge funds are holding shares in GB:RENX
              ---

              Renalytix AI Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -1073.17%
              Trailing 12-Months
              Asset Growth
              -77.97%
              Trailing 12-Months

              Company Description

              Renalytix AI Plc

              Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
              ---

              RENX Earnings Call

              Q3 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Renalytix AI
              Nano-X Imaging
              ClearPoint Neuro
              Veracyte
              Fate Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis